Skip to main content

Decisiv Closes KEA Advisors Acquisition, Expanding Performance as a Platform

Deal adds decades of benchmarking and advisory expertise to the company’s Performance as a Platform™ (PaaP) initiative Reston, Virginia, Sept. 08, 2026 (GLOBE NEWSWIRE) — Decisiv®, Inc., the industry leader in Service Relationship Management (SRM) solutions, today announced the successful closing of its acquisition of KEA Advisors, uniting 25 years of dealership performance improvement, benchmarking, advisory expertise, and the PULSE Reporting system with the industry leading Decisiv SRM™ platform. The combination, first announced in March 2026, accelerates the delivery of Performance as a Platform™ (PaaP), Decisiv’s AI-driven initiative for commercial vehicle service and performance. The two companies have collaborated for years, most recently integrating Decisiv Status Tracker into PULSE Reporting to...

Continue reading

QEP Acquires Spray-Lock®, Expanding Its Adhesives Manufacturing Platform

BOCA RATON, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) — Q.E.P. CO., INC. (OTCQX: QEPC) (the “Company” or “QEP”) today announced that, on September 1, 2026, it completed the acquisition of substantially all of the assets of Spray-Lock, Inc. (“Spray-Lock”), a developer, manufacturer and distributor of premium aerosol spray adhesives for flooring and wall applications. Financial terms of the transaction were not disclosed. The acquisition advances QEP’s strategy of broadening its core adhesives platform by adding Spray-Lock’s patented spray-applied technology, proprietary formulations and technical expertise to QEP’s existing flooring installation solutions. Spray-Lock’s water-based formulations are designed to simplify application, use less adhesive than traditional trowel-applied alternatives and offer moisture and pH tolerance, low-VOC...

Continue reading

Raymer Elite Reporting Joins Lexitas

HOUSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) — Lexitas, a leading provider of technology-enabled litigation services and a portfolio company of funds advised by Apax, today announced that Raymer Elite Reporting has joined Lexitas. Founded by Wendy Raymer, Raymer Elite Reporting is a highly respected provider of court reporting and litigation support services, known for its exceptional client service, experienced reporter network, and commitment to delivering accurate and reliable reporting solutions. Serving attorneys, law firms, corporations, and insurers, Raymer Elite has built a strong reputation for professionalism, responsiveness, and quality. “I’m pleased to welcome Raymer Elite Reporting to the Lexitas family,” said Nishat Mehta, CEO of Lexitas. “Wendy has built an outstanding reputation for delivering exceptional service and...

Continue reading

GE Aerospace to Acquire Consolidated Precision Products (CPP), Expanding Mission-Critical Castings Capacity

CINCINNATI, Sept. 08, 2026 (GLOBE NEWSWIRE) —Investing in castings capacity to support strong demand across commercial engines, aftermarket and defense $11.75 billion transaction, expected to be accretive-a) to adjusted EPS* and free cash flow* in the first year Strong near and long-term value creation for customers and shareholdersGE Aerospace (NYSE:GE) announced today that it has signed an agreement to acquire Consolidated Precision Products (CPP), a leading manufacturer of highly engineered castings, from private investment firms Warburg Pincus and Berkshire Partners.  GE Aerospace Chairman and CEO H. Lawrence Culp, Jr., said, “Investing in mission-critical casting capacity is needed to support the strong simultaneous demand across commercial engines, aftermarket and defense. By combining GE Aerospace’s technology capabilities...

Continue reading

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

Merger unites Sernova’s Cell Pouch Bio-hybrid Organ with Seraxis’ stem cell-derived pancreatic islet cells and in-house cGMP manufacturing The combined entity will operate under the name BetaNova Biotherapeutics, Inc. SR-02 allogeneic islet cell therapy Phase 1/2 clinical trial in T1D expected to dose patients Q1 2027 under an FDA-cleared IND (NCT07581197) with data anticipated by mid-year SR-03 next-generation gene-edited islet cell therapy targeting immune evasion; IND submission expected H2 2027 US$10 million non-brokered financing secured to fund initial development plans to key milestones Merger expected to close in November 2026, subject to shareholder approval Upon completion of the Merger, BetaNova intends to seek listing on NASDAQ in Q1 2027, subject to satisfaction of applicable listing requirements and approvals Webinar...

Continue reading

Form 8.3 – [APTITUDE SOFTWARE GROUP PLC – 07 09 2026] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree APTITUDE SOFTWARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: APTITUDE...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 07 09 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Aktsiaselts Infortar subsidiary OÜ Infortar Agro to acquire a 100% shareholding in Lithuanian agricultural company Litagra

Aktsiaselts Infortar subsidiary OÜ Infortar Agro (hereinafter “Infortar Agro”) and AB Invalda INVL indirectly through UAB Cedus Invest, Gintaras Kateiva and Adomas Grigaitis (hereinafter the “Seller”) entered into an agreement on 7 September 2026, in which the Seller will sell to Infortar Agro 100% of the shares in its Lithuanian subsidiary UAB Litagra (“Litagra”). Litagra is a Lithuanian agricultural group established in 1991. Its activities include dairy and crop farming, poultry farming, feed production and other agriculture-related activities.  The Litagra Group includes UAB Joniškio Grūdai, UAB Litagros Žemės Ūkio Centras and Agrohold Estonia OÜ, all of which are wholly owned by UAB Litagra. In addition to Litagra UAB, the Litagra Group comprises 34 companies. The structure of the acquired companies is attached to this announcement. The...

Continue reading

Correction: Form 8.3 – LondonMetric Property Plc & Schroder Real Estate Investment Trust Limited

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date...

Continue reading

Schouw & Co. share buy-back programme, week 36 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. As outlined in Company Announcement no. 48 of 14 August 2026, the programme was extended with up to DKK 170 million, increasing the total amount of which Schouw & Co. will acquire shares to up to DKK 410 million. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 28 August 2026 325,483 666.30 216,869,061    Monday,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.